Zimbabwe has turned down a significant US healthcare agreement worth 367 million US dollars (272 million pounds) over five years because of the United States' request for sensitive biological samples.
This rejection came to light after a internal memorandum dated December was leaked, indicating that Head of State Emmerson Mnangagwa believed the arrangement was "unbalanced".
An official spokesman has since clarified that the United States was seeking health data for scientific study and profit while was not willing to guarantee the benefits from any future vaccines.
"We must now begin the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had furnished over $1.9bn in health funding to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for more talks to reach a agreement agreeable to both sides so the nation's critical HIV treatment initiative can proceed.
Wider Background
This rejection comes after a similar case in Kenya, where a high court halted a related deal with the US after legal challenges were raised about the safety of citizens' health data.
After returning to office recently, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
The agency had administered aid for the US government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing government-to-government deals to boost transparency and accountability.
Based on reports, Sixteen African countries have so far agreed to these new health pacts, constituting more than $18.3bn in new funding.
Details of the Declined Deal
This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this collaboration would have delivered extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million currently on HIV treatment through US-supported initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"The proposal required Zimbabwe to provide its genetic material and health information for a long time, without any corresponding promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that provided information," Mangwana explained.
"Effectively, our country would provide the basic resources for scientific discovery with no assurance that the end products would be available to our population should a new health crisis emerge."
Sovereignty and Global Health
He also said that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were upending systems already set up through the international organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to deal with future global health emergencies.
"This mechanism is designed to ensure that when a nation contributes its data, the benefits – such as medicines and cures – are distributed fairly, not commercialised solely by those with the resources to create them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We encourage continued dialogue with our American counterparts on how future co-operation could be designed in a way that respects the independence and dignity of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the official position, but urged that negotiations must proceed given that much of the country's Aids initiatives were funded by external financing.
"If specific concerns arise, such as those involving information security or implementation frameworks, these can frequently be resolved via detailed discussion and negotiated safeguards," the group commented.
The halted deal emphasises the ongoing debate between receiving crucial foreign assistance and protecting national sovereignty in an increasingly interconnected world.